Menu
Log in
Forgot password
Log in
Forgot password

News

  • Home
  • Resources
  • Literature Updates
  • Docetaxel, Cisplatin, and 5-FU Triplet Therapy as Conversion Therapy for Locoregionally Advanced Unresectable Esophageal Squamous Cell Carcinoma

Docetaxel, Cisplatin, and 5-FU Triplet Therapy as Conversion Therapy for Locoregionally Advanced Unresectable Esophageal Squamous Cell Carcinoma

01 Feb 2023 6:51 PM | Michele O'Bright (Administrator)
Wing-Lok Chan MBBS, Cheuk-Wai Choi PhD, Ian Yu-Hong Wong MBBS, Terence Hon-Ting Tsang MBBS, Adrian Tin-Chung Lam MBBS, Rosa Pui-Ying Tse MBChB, K. K. Chan MBBS, Claudia Wong MBBS, Betty Tze-Ting Law MBBS, Emina Edith Cheung BSc, Siu-Yin Chan MBBS, Ka-On Lam MBBS, Dora Kwong MD & Simon Law MS

Read Abstract:  Docetaxel, Cisplatin, and 5-FU Triplet Therapy as Conversion Therapy for Locoregionally Advanced Unresectable Esophageal Squamous Cell Carcinoma

Affiliated Societies



International  Interdisciplinary  Everything Esophageal


The International Society for Diseases of the Esophagus is a 501(c)3 non-profit organization. © International Society for Disease of the Esophagus – ISDE 2024 | Any unauthorized use or reproduction of the content is prohibited without explicit permission.

General Inquiries: info@isde.net
Membership Questions: membership@isde.net

Powered by Wild Apricot Membership Software